FIELD: chemistry.
SUBSTANCE: described are compounds of formula I , where R1 and R2, together with carbon atoms Ca and Cb to which they are bonded, form or R3, R5, R6 and R7 independently denote hydrogen, C1-C6alkyl or C3-C8cycloalkyl; and R4 denotes 2,2-dimethylpropyl, 3-methylbutyl, isopropyl, tert-butyl, cyclopropylmethyl, cyclopentylmethyl, 3,3-dimethylbutyl or 1-cyclopropyl-1-methylethyl. The invention also relates to pharmaceutically acceptable salts of such compounds and pharmaceutical compositions containing such compounds of salts thereof. The disclosed compounds and compositions are capable of inhibiting activity of the 11-β-hydroxysteroid dehydrogenase 1 (11-β-HSD1) enzyme.
EFFECT: possibility of using derivatives for treating and preventing diabetes, obesity, eating disorders, dyslipidaemia and hypertension.
22 cl, 1 tbl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
PYRIDAZINE DERIVATIVES | 2006 |
|
RU2401832C2 |
PYRIDAZINE DERIVATIVES AS RORc MODULATORS | 2017 |
|
RU2757571C2 |
BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
TETRAHYDROCINNOLINE DERIVATIVES | 2009 |
|
RU2541533C2 |
NEW LIGANDS OF CANNACBINOID RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHOD FOR PRODUCING THEREOF | 2006 |
|
RU2420518C2 |
11β-HYDROXYSTEROID DIHYDROGENASE INHIBITORS | 2008 |
|
RU2440989C2 |
PYRAZOLONE DERIVATIVES | 2006 |
|
RU2407737C2 |
BETA-SECRETASE INHIBITORS | 2016 |
|
RU2712272C2 |
11β-SUBSTITUTED 19-NORSTEROIDS, METHOD OF THEIR SYNTHESIS, COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2140423C1 |
DIKETOHYDRAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING SUCH DERIVATIVES AS ACTIVE INGREDIENT, AND THEIR USE | 2003 |
|
RU2368600C2 |
Authors
Dates
2011-05-10—Published
2007-06-26—Filed